Table 2.

Immunophenotyping at death

	% of Total cells
	GFP+	GFP+/CD11b+	GFP+/Gr1+	GFP+/CD3+	GFP+/B220+
Peripheral blood
Vector	8.69 ± 6.51	4.78 ± 1.44	1.81 ± 0.07	0.046 ± 0.04	0.002 ± 0.005
BCR/ABL	82.12 ± 8.53	69.20 ± 16.69	16.78 ± 2.63	0.51 ± 0.22	6.72 ± 6.35
ΔUBD	78.78 ± 18.49	69.89 ± 16.48	39.58 ± 7.15	0.33 ± 0.20	3.75 ± 1.49
Bone marrow
Vector	9.80 ± 9.09	7.41 ± 3.97	4.11 ± 1.96	0.64 ± 0.30	0.003 ± 0.002
BCR/ABL	69.19 ± 17.23	55.38 ± 16.17	16.3 ± 3.58	0.82 ± 0.60	3.61 ± 3.58
ΔUBD	69.91 ± 16.76	61.24 ± 17.15	28.88 ± 6.87	0.68 ± 0.36	2.75 ± 1.61
Spleen
Vector	5.67 ± 3.74	4.74 ± 1.73	2.37 ± 0.88	1.85 ± 0.59	0.005 ± 0.003
BCR/ABL	65.12 ± 9.07	39.97 ± 17.11	15.95 ± 2.36	2.94 ± 1.44	4.61 ± 2.29
ΔUBD	72.09 ± 14.96	60.53 ± 17.14	34.5 ± 7.23	1.46 ± 0.74	3.16 ± 1.71

Immunophenotyping was performed as described in Methods.